Authors' response to Marras and Oakes, 'piecing together the puzzle of progression and mortality in Parkinson's disease'

被引:1
作者
Holford, Nicholas H. G. [1 ]
Vu, Thuy C. [2 ]
Nutt, John G. [3 ]
机构
[1] Univ Auckland, Dept Pharmacol & Clin Pharmacol, Auckland 1, New Zealand
[2] Amgen Inc, Dept Pharmacokinet & Drug Metab, Thousand Oaks, CA 91320 USA
[3] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA
关键词
DISABILITY; SURVIVAL; LEVODOPA;
D O I
10.1111/j.1365-2125.2012.04465.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1370 / 1371
页数:2
相关论文
共 7 条
[1]   Disease progression and pharmacodynamics in Parkinson disease - Evidence for functional protection with levodopa and other treatments [J].
Holford, Nicholas H. G. ;
Chan, Phylinda L. S. ;
Nutt, John G. ;
Kieburtz, Karl ;
Shoulson, Ira .
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2006, 33 (03) :281-311
[2]   Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease [J].
Lees, AJ .
BRITISH MEDICAL JOURNAL, 1995, 311 (7020) :1602-1607
[3]   Survival in Parkinson disease - Thirteen-year follow-up of the DATATOP cohort [J].
Marras, C ;
McDermott, MP ;
Rochon, PA ;
Tanner, CM ;
Naglie, G ;
Rudolph, A ;
Lang, AE .
NEUROLOGY, 2005, 64 (01) :87-93
[4]   Piecing together the puzzle of progression and mortality in Parkinson's disease [J].
Marras, Connie ;
Oakes, David .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (02) :264-266
[5]  
SHOULSON I, 1993, NEW ENGL J MED, V328, P176, DOI 10.1056/NEJM199301213280305
[6]   Progression of motor and nonmotor features of Parkinson's disease and their response to treatment [J].
Vu, Thuy C. ;
Nutt, John G. ;
Holford, Nicholas H. G. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (02) :267-283
[7]   Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease [J].
Vu, Thuy C. ;
Nutt, John G. ;
Holford, Nicholas H. G. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (02) :284-295